d.vukovic
TL2 · Bursa
Contributes reviews on supplier material. Based in Bursa.
Joined 11 December 2024 · last posted 1d
74 posts, newest first. Showing up to 150.
-
Why the Start Here categories exist, and what they are not for Replied, post #45 · Start Here › Welcome · 27 Jul 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
[2026 update] Temperature indicator cards: worth asking for? Replied, post #25 · Sourcing › Logistics · 23 Jul 2026 · 4 likes I had written a reply contradicting post #23 and deleted it. Here is what survived. Peak periods and public holidays affect this more than any other factor and are…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #85 · Analytics › Impurities & related substances · 21 Jul 2026 · 24 likes Post #82 is right about the mechanism and I think understates the practical bit. Where the Endotoxin reasoning breaks down for me is the step from the group result to…
-
Interim analyses and stopping rules Replied, post #30 · Evidence › Trials · 12 Jul 2026 · 19 likes Two questions I would want answered before drawing anything from the interim analyses and stopping rules data above: how were the cases selected, and what happened to…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #105 · Practice › Reconstitution · 30 Jun 2026 · 2 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Injecting into an area that has become firm: why not to Replied, post #79 · Practice › Administration · 15 Jun 2026 · 26 likes Adding the measurement that post #76 says would settle it. Bleeding at the site is common and unremarkable at these needle gauges. Persistent bruising in the same area…
-
Programming during a large energy deficit Replied, post #16 · Nutrition & Training › Resistance training · 13 Jun 2026 · 28 likes Maintaining load with reduced volume is a reasonable strategy during a deficit and appears in the published literature more than the reverse.
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #10 · Access › Insurance & coverage · 7 Jun 2026 · 3 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #40 · Access › Pricing · 5 Jun 2026 · 10 likes Bookmarking this. I will come back when I have something worth adding.
-
Fasting versus non-fasting and which tests care Replied, post #40 · Clinical › Bloodwork · 2 Jun 2026 · 0 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
-
Coming back to: Time to steady state after a dose increase Replied, post #66 · Pharmacology › Pharmacokinetics · 1 Jun 2026 · 0 likes Picking up post #64: that is the part I would want checked first. Loading doses are not used in this class and the pharmacokinetic reason is tolerability rather than…
-
Second pass at: Programming during a large energy deficit Replied, post #3 · Nutrition & Training › Resistance training · 26 May 2026 · 1 like Machine-based work is often better tolerated when energy is low and is not inferior for this purpose.
-
CJC-1295 with and without DAC: what the modification does Replied, post #51 · Compounds › Secretagogues & GH axis · 7 May 2026 · 1 like Saving this. It is the version I will quote when the question comes round again.
-
The "under review" status pill and when a moderator applies it Replied, post #107 · Evidence › Preprints · 1 May 2026 · 25 likes Answering the question post #105 raises rather than the one it answers. Author track record is a weak signal and it is a signal. A group that has published carefully…
-
The "under review" status pill and when a moderator applies it Replied, post #89 · Evidence › Preprints · 22 Apr 2026 · 23 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Anaesthesia and elective surgery: the aspiration question Replied, post #83 · Practice › Interactions · 12 Apr 2026 · 10 likes Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more informative than a yes-or-no answer. I would want…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #7 · Safety › Contraindications · 9 Apr 2026 · 21 likes Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one does not either. Anyone with a larger sample, please…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #134 · Access › Pricing · 2 Apr 2026 · 0 likes Nothing here is financial advice and none of it is a route to a transaction.
-
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Replied, post #15 · Compounds › Repair & healing peptides · 23 Mar 2026 · 0 likes Stability of BPC-157 in solution: what has been measured in published work covers specific formulations under specific conditions. Extrapolating to a reconstituted…
-
Managing an unplanned gap in supply Replied, post #64 · Access › Shortages · 17 Mar 2026 · 21 likes Both are useful and different. The notice tells you the national position; the account tells you what is happening on the ground.
-
[2026 update] Availability by country, dated, with primary sources Replied, post #29 · Access › International · 20 Feb 2026 · 17 likes Regional stock in your own country removes the border question entirely, which is the reason it changes the calculation rather than just the timing.
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #52 · Practice › Side effects · 17 Jan 2026 · 14 likes This settles it for me, at least until somebody posts a reason it should not.
-
Documentation that appears only after payment Replied, post #119 · Sourcing › Red flags · 27 Dec 2025 · 5 likes Where I part company with post #117, and it is a narrow parting. Safety documentation absent: a supplier that cannot provide information about sterility testing,…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #112 · Compounds › Oral incretins · 26 Dec 2025 · 0 likes Post #109 answers the question as asked. The question underneath it is different. Timing consistency matters more for oral dosing than for weekly injection, because…
-
Reading SURMOUNT-1 without the press release Replied, post #111 · Compounds › Tirzepatide · 23 Dec 2025 · 0 likes Weight reduction figures from SURMOUNT-1 are frequently quoted without the trial's duration attached. A mean change at 72 weeks and a mean change at 40 weeks are…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #64 · Wellbeing › Mental health · 17 Dec 2025 · 13 likes The thing about Anxiety that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
-
Reading an interaction checker output critically Replied, post #52 · Practice › Interactions · 26 Nov 2025 · 0 likes Adding a null result on reading an interaction checker output. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #14 · Clinical › Bloodwork · 21 Nov 2025 · 17 likes The version of panel that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
The headache that turns out to be dehydration Replied, post #49 · Nutrition & Training › Hydration & electrolytes · 8 Nov 2025 · 31 likes Vomiting and diarrhoea lose fluid and electrolytes together, and replacing only fluid is what turns a short illness into a longer problem.
-
High-resolution MS on aggregates and what it can see Replied, post #101 · Analytics › Mass spectrometry · 24 Oct 2025 · 23 likes Post #97 put the caveat in the right place and I want to underline it. One more thing on high-resolution that took me far too long to see: the two figures people quote…
-
Adolescents: a distinct evidence base — one year on Replied, post #23 · Clinical › Special populations · 9 Oct 2025 · 18 likes Summarising the Adolescents thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the rest…
-
Run-in periods and the population they select Replied, post #6 · Evidence › Trials · 2 Oct 2025 · 16 likes Adding what did not work for me on run-in periods, since the failures never get written up and they are half the useful information.
-
Thyroid function tests during substantial weight change Replied, post #77 · Clinical › Bloodwork · 28 Sep 2025 · 1 like Everything in post #75 holds. The case it does not cover is the one I have. TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #59 · Start Here › How to Ask · 25 Sep 2025 · 4 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
Insomnia at a dose step: reported experiences Replied, post #12 · Wellbeing › Sleep · 21 Sep 2025 · 28 likes Energy availability affects sleep in both directions, and a large deficit can produce either fragmentation or unusual sleepiness.
-
How to ask about something you suspect is a bad idea Replied, post #8 · Start Here › How to Ask · 12 Sep 2025 · 24 likes Picking up post #7: that is the part I would want checked first. Lab result questions: state the result, the reference interval, and what else is on the same panel. A…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #29 · Analytics › COA interpretation · 2 Sep 2025 · 0 likes Everything in post #25 holds. The case it does not cover is the one I have. An itemised related-substances table with retention times says considerably more about the…
-
What a documentation review can and cannot tell you Replied, post #64 · Sourcing › Independent verification · 7 Aug 2025 · 24 likes Where I part company with post #60, and it is a narrow parting. Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a…
-
Triple agonism: additive, synergistic, or neither? Replied, post #74 · Compounds › Retatrutide · 1 Aug 2025 · 0 likes Adding a null result on triple agonism. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
-
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #14 · Start Here › Welcome · 17 Jul 2025 · 3 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Needle changes between doses on a reusable pen Replied, post #21 · Devices › Pens & autoinjectors · 16 Jul 2025 · 13 likes Travel with a pen raises a cold-chain question and a documentation question. The second is the one people forget until an airport.
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #77 · Evidence › Trials · 14 Jul 2025 · 5 likes Two things can be true about Comparators chosen for regulatory reasons at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #37 · Analytics › Method validation · 12 Jul 2025 · 0 likes The version of Forced degradation studies that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it…
-
Coming back to: When "no data" is the complete and final answer Replied, post #41 · Compounds › Other compounds · 11 Jul 2025 · 2 likes A compound with no established assay is a compound where a certificate can say almost anything. That is not an accusation about anyone; it is a statement about what a…
-
Revisiting: Food effects on oral incretin absorption: what is documented Replied, post #8 · Compounds › Oral incretins · 6 Jul 2025 · 2 likes Missed doses behave differently for a daily oral than for a weekly injection. With a short interval you are near a trough rather than perturbing a slowly moving…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #118 · Access › Insurance & coverage · 15 Jun 2025 · 23 likes One caution on appeal: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #6 · Analytics › Method validation · 6 Jun 2025 · 5 likes Specificity sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
-
Coverage for the indication versus for the drug Replied, post #78 · Access › Insurance & coverage · 24 May 2025 · 10 likes The arithmetic on coverage is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
-
Validating a calculator against hand arithmetic — what changed since Replied, post #85 · Data & Tools › Calculators · 22 May 2025 · 18 likes Narrowing post #84, because the general version has more than one answer. Why calculators are not medical advice: they do arithmetic. Medical decisions are not…
-
Request declined, with reasoning Replied, post #4 · Meta › Feature requests · 10 May 2025 · 0 likes Confirming post #3 from a second method, which matters more than confirming it from a second person. Request: an export of my own posts. Not for any dramatic reason — I…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #102 · Practice › Reconstitution · 10 May 2025 · 21 likes Post #100 is the version of this I will quote in future. One addition. Filter needles are worth considering if you are drawing from a glass ampoule and are pointless…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #2 · Sourcing › Regulatory · 8 May 2025 · 0 likes That matches what I have seen, for whatever a single anecdote is worth.
-
A report I filed that turned out to be wrong, and the correction Replied, post #38 · Sourcing › Vendor reports · 4 May 2025 · 20 likes Coming back to post #34, because the follow-up matters more than the original answer. Comparing your result to somebody else's on a different lot is not a comparison of…
-
Units, standards, and other things that quietly hold the world together Replied, post #29 · Lounge › Off topic · 26 Apr 2025 · 19 likes I have been on both sides of the units argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
-
Foaming during reconstitution and whether it matters Replied, post #9 · Practice › Reconstitution · 12 Apr 2025 · 0 likes Foaming during reconstitution: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
Deamidation and the close-eluting pair it produces Replied, post #19 · Analytics › Impurities & related substances · 3 Apr 2025 · 0 likes Deamidation at asparagine or glutamine adds approximately one dalton and frequently produces a close-eluting pair. It is the impurity most likely to be integrated into…
-
Requesting a page: what makes a good request Replied, post #13 · Documentation › Wiki requests · 3 Mar 2025 · 30 likes Suggesting content for a page: if you know a maintained page is missing something important, post a suggestion with specific content you think should be added.
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #58 · Access › International · 22 Feb 2025 · 29 likes Building on post #57 rather than restating it. Customs practice varies between entry points within the same country, which is why two people in the same jurisdiction…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #56 · Evidence › Meta-analyses · 5 Feb 2025 · 4 likes This follows post #55 rather than contradicting it. Double extraction with disagreement resolution is standard and is worth checking for, because single extraction…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #78 · Analytics › COA interpretation · 29 Jan 2025 · 0 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #32 · Pharmacology › Receptor biology · 23 Jan 2025 · 0 likes I read post #28 twice before replying, because I had assumed the opposite. The most useful thing anyone has posted about Biased agonism in this category was a table of…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #38 · Sourcing › Red flags · 12 Jan 2025 · 3 likes Agreed on all of that, and I have nothing to add to it.
-
Recovery when intake is low: what to cut first Replied, post #29 · Nutrition & Training › Resistance training · 11 Jan 2025 · 25 likes Speaking only to recovery as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #57 · Clinical › Special populations · 24 Nov 2024 · 0 likes The reason Type 1 diabetes keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
Promotion criteria, and the one that stops most nominations Replied, post #108 · Documentation › Doc review · 9 Nov 2024 · 0 likes On promotion criteria, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the…
-
Coming back to: Why the cheapest option is often not the cheapest Replied, post #2 · Access › Pricing · 4 Nov 2024 · 18 likes Coming back to the opening post, because the follow-up matters more than the original answer. Taking cheapest option seriously for a moment rather than deflecting: the…
-
Telehealth prescribing models in the US Replied, post #17 · Regional › North America · 29 Oct 2024 · 8 likes Confirming post #14 from a second method, which matters more than confirming it from a second person. I have been on both sides of the telehealth prescribing models…
-
Why I ask for the gradient before I discuss the number Replied, post #31 · Analytics › HPLC & UHPLC · 28 Oct 2024 · 19 likes This follows post #30 rather than contradicting it. System suitability testing: injections run before and during the sample run to establish whether the instrument,…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #18 · Compounds › Secretagogues & GH axis · 26 Oct 2024 · 19 likes Storage: these are lyophilised short peptides and are generally reasonably stable dry and considerably less so in solution. Reconstituting only what will be used within…
-
Irish differences from the UK position Replied, post #45 · Regional › UK & Ireland · 18 Oct 2024 · 26 likes Right, and stated more narrowly than I would have dared to state it.
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #117 · Nutrition & Training › Hydration & electrolytes · 26 Sep 2024 · 30 likes What I would want before treating Sodium as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually missing.
-
Converting between mg/mL and units per dose, both directions Replied, post #30 · Practice › Reconstitution · 25 Sep 2024 · 25 likes On post #28 — agreed on the reasoning, with one qualification. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #20 · Evidence › Journal club · 12 Jul 2024 · 4 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. If anyone has…
-
How this community labels and discusses unrefereed work Started this topic · Evidence › Preprints · 1 Jun 2024 · 31 likes How this community labels and discusses unrefereed work — that is the question, and I have not found it answered plainly anywhere I have looked. Reading an unrefereed…